𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Gemcitabine-induced hemolytic uremic syndrome in ovarian carcinoma

✍ Scribed by Nishant Kalra; Rahul Kad; Sayed Osama

Publisher
Springer
Year
2007
Tongue
English
Weight
299 KB
Volume
12
Category
Article
ISSN
1341-9625

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Is therapeutic plasma exchange indicated
Is therapeutic plasma exchange indicated for patients with gemcitabine-induced hemolytic uremic syndrome?
✍ Ethan McCaleb Gore; Benjamin Scott Jones; Marisa B. Marques πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 76 KB

Atypical hemolytic uremic syndrome (aHUS) has been described as an uncommon complication of gemcitabine. In this review, we discuss the diagnosis of gemcitabine-induced aHUS (GiHUS) and the published experience with therapeutic plasma exchange (TPE). To illustrate GiHUS, we present a patient who dev

A review of hemolytic uremic syndrome in
A review of hemolytic uremic syndrome in patients treated with gemcitabine therapy
✍ Man C. Fung; Anna Maria Storniolo; Binh Nguyen; Michael Arning; William Brookfie πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 104 KB πŸ‘ 2 views

## BACKGROUND. Hemolytic uremic syndrome (HUS) is a rare condition that occasionally is reported in cancer patients. Recently it has been observed that gemcitabine rarely may be associated with this condition. METHODS. The manufacturer's safety database and literature were reviewed for any report

Steroids in the hemolytic uremic syndrom
Steroids in the hemolytic uremic syndrome
✍ Nestor Perez; Francisco Spizzirri; Ricardo Rahman; Angela Suarez; Cintia Larrubi πŸ“‚ Article πŸ“… 1998 πŸ› Springer 🌐 English βš– 142 KB